Abstract
Senaca observed early in the first century A.D., “the illustrious founder of the guild and profession of medicine [Hippocrates] remarked that women never lost their hair or suffered from pain in the feet; and yet nowadays they run short of hair and are afflicted with gout … in rivalling male indulgences, they have also rivalled the ills to which men are heirs“.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Centers for Disease Control and Prevention (1993) Annual summary of births, marriages, divorces, and deaths: United States, 1992. Monthly vital statistics report from the Centers for Disease Control and Prevention, vol 14, pp 1–24
Sealey JE, Cholst I, Glorioso N, Troffa C, Weintraub ID, James GD, Laragh JH (1987) Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle. J Clin Endocrinol Metab 65: 1–5
Horowitz MC (1993) Cytokines and estrogen in bone: anti-osteoporotic effects. Science 260: 626
Colditz GA, Willet WC, Stampfer MJ, Rosher B, Speizer FF, Hennekens CH (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316: 1105–1110
Barrett-Connor E, Bush TL (1991) Estrogen and coronary heart disease in women. JAMA 265: 1861–1867
Keaney JF, Shwaery GT, Xu A, Nicolosi RJ, Foxall TL, Vita JA (1993) Preserva¬tion of endothelial function in hypercholesterolemia through the antioxidant properties of estrogens. Circulation 88: 1–79
Meilahn EN, Kuller LH, Matthews KAA, Kiss JE (1992) Hemostatic factors according to menopausal status and use of hormone replacement therapy. Ann Epidemiol 2: 445–455
Magness RR, Rosenfeld CR (1989) Local and systemic estradiol- 17beta: effects on uterine and systemic vasodilation. Am J Physiol XX: E536–E542
Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P (1993) Beneficial effect of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342: 133–136
Ravnikar VA (1993) Hormone replacement therapy in the primary prevention of cardiovascular disease: benefits, risks, and compliance issues. In: Wenger NK, Speroff L, Packard B (eds) Cardiovascular health and disease in women. Le Jacq Communications, Greenwich, pp 181–187
Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016–1037
Laragh JH, Sealey JE, Ledingham JGG, Newton MA (1967) Oral contracept-ives: renin, aldosterone and high blood pressure. JAMA 201: 918–922
Baird DT, Glasier AF (1993) Hormonal contraception. N Engl J Med 328: 1543–1549
Russel RP, Sullivan MA (1970) The pill and hypertension. Johns Hopkins Med J 127: 287–293
Woods JW (1988) Oral contraceptives and hypertension. Hyertension 11 [Suppl II]: II. 11–II. 15
McCaffrey TA (1985) Preliminary dissertation. Purdue University, Indiana
Van Beresteyn ECH, van’t Hoff MA, de Waard H (1989) Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women: a mixed longitudinal study. Am J Epidemiol 129: 947–955
Luotola H (1983) Blood pressure and hemodynamics in postmenopausal women during estradiol 17-beta substitution. Ann Clin Res 15 [Suppl 38]: 1–121
Laragh JH (1972) Oral contraceptive hypertension. Postgrad Med 52: 98–105
Steingold KA, Matt DW, DeZiegler D, Sealey JE, Fratkin M, Reznikov S (1991) Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. J Clin Endocrinol Metab 73: 275–280
DeLignieres B, Baevant A (1986) Biological effects of estradiol-17beta in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 62: 1
Derkx FHM, Stuenkel C, Schalekamp MPA, Visser W, Huisveld IH, Schalekamp MADH (1986) Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 63: 1008–1015
Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C (1987) The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76: 753–758
Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH (1988) On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship. J Hypertension 6: 763–777
Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August P, Thaler I, Levron J, Laragh JH (1993) Estradiol and progesterone related increases in the renin- aldosterone system during ovarian stimulation and early pregnancy (submitted to J Clin Endocrinol Metab )
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Cacciabaudo, J.M., Sealey, J.E. (1994). Hormone Replacement Therapy and Hypertension: Relationship to the Renin-Angiotensin System. In: Safar, M.E., Stimpel, M., Zanchetti, A. (eds) Hypertension in Postmenopausal Women. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79077-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-79077-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58144-4
Online ISBN: 978-3-642-79077-5
eBook Packages: Springer Book Archive